HLA Typing for Transplant Market Size & Share, by Technology (Non-Molecular Assay and Molecular Assay); Products (Instruments, Reagents & Consumables and Software & Services); Application (Diagnostic Applications and Research Applications) and By End-User (Independent Reference Laboratories, Hospitals & Transplant Centers, Research Laboratories, Academic Institutions and Commercial Service Providers) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2024-2036

  • Report ID: 2629
  • Published Date: Oct 15, 2024
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2024-2036

HLA Typing for Transplant Market size was over USD 803.65 million in 2023 and is anticipated to cross USD 1.75 billion by 2036, witnessing more than 6.2% CAGR during the forecast period i.e., between 2024-2036. In the year 2024, the industry size of HLA typing for transplant is estimated at USD 843.51 million.

The market is projected to witness a significant growth owing to rising transplant failures which led an upsurge to match the organ transplant feasibility before the surgery to avoid any kind of loss. Factors such as a rise in the number of transplantation procedures and the number of older adult organ donors are anticipated to support the development of the global market. According to the World Health Organization, around 100,800 solid organ transplants are performed every year worldwide, out of which 69 400 are kidney transplants (46% from living donors), 20 200 are liver transplants (14.6% from living donors), 5400 are heart transplants, 3400 are lung transplants and 2400 are pancreas transplants. Additionally, an increase in technological advancements in HLA typing field coupled within the investment and funding for research purposes is estimated to drive the global market over the forecast period.

 


Get more information on this report: Request Free Sample PDF

HLA Typing for Transplant Sector: Growth Drivers and Challenges

Growth Drivers

Escalating Number of Transplantation Procedures to Enhance the Global Market

HLA typing for the transplant market is projected to observe notable growth owing to the rising numbers of transplantation procedures and an increase in the number of older adult organ donors. Additionally, an increase in technological advancements in HLA typing field coupled within the investment and funding for research purpose is estimated to drive the global market over the forecast period. Furthermore, a notable gap between demand and supply of organ donations resulting in escalated patient waiting time coupled with increasing awareness levels due to government and non-government organizations is estimated to fuel the market over the forecast period.

Challenges

High Cost of Devices and Stringent Rules Norms

The global HLA typing for the transplant market is projected to hindered by factors such as high costs associated with molecular HLA typing, stringent policies, and norms coupled with a limited number of medical centers for organ donation and transplantation procedures.

 

 

HLA Typing for Transplant Market: Key Insights

Base Year

2023

Forecast Year

2024–2036

CAGR

6.2%

Base Year Market Size (2023)

USD 803.65 million

Forecast Year Market Size (2036)

USD 1.75 billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

HLA Typing for Transplant Segmentation

The HLA typing for transplant market is segmented by technology, by-products, by application & by end-user, out of which, the molecular assay of technology sector segment is anticipated to hold leading shares in the market on account of the benefits offered by molecular assays such as low turnaround time, high procedural efficacy, the study of multiple samples, and real-time sample analysis. On the contrary, the diagnostic segment of the application sector accounted for the largest share owing to the rising adoption of molecular assay procedures for pathogen detection & histocompatibility testing, and the increasing incidence of chronic diseases. Additionally, independent reference laboratories segment of the end-user sector is estimated to witness a robust growth owing to the increasing number of research & development activities outsourced by pharmaceutical & biotechnology, rapid modernization and automation of diagnostic laboratories, and the growing number of organ transplantation procedures.

Our in-depth analysis of the global market includes the following segments:

           By Technology

  • Non-Molecular Assay
  • Molecular Assay

             By Products

  • Instruments
  • Reagents & Consumables
  • Software & Services

 

 

            Application

  • Diagnostic Applications
  • Research Applications

            End-User

  • Independent Reference Laboratories
  • Hospitals & Transplant Centers
  • Research Laboratories
  • Academic Institutions
  • Commercial Service Providers
 

Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.

Customize this Report

HLA Typing for Transplant Industry - Regional Synopsis

Based on geographically, the HLA typing for transplant market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa region.

North America industry is poised to account for largest revenue share by 2036, on account of the presence of a highly developed healthcare system, large volume of organ transplantation procedures performed in the region, high adoption of innovative transplant diagnostic technologies (includes HLA typing) among medical professionals and technological advancements in the field of transplant diagnostics.

Get more information on this report: Request Free Sample PDF

Companies Dominating the HLA Typing for Transplant Landscape

    • Thermo Fisher Scientific, Inc.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Immucor, Inc.
    • Illumina, Inc.
    • CareDx, Inc.
    • QIAGEN N.V.
    • Bio-Rad Laboratories, Inc.
    • F. Hoffman-La Roche Ltd.
    • Biofortuna Limited
    • Takara Bio Inc.
    • Omixon Inc.

Author Credits:  Radhika Pawar


  • Report ID: 2629
  • Published Date: Oct 15, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of HLA typing for transplant is estimated at USD 843.51 million.

HLA Typing for Transplant Market size was over USD 803.65 million in 2023 and is anticipated to cross USD 1.75 billion by 2036, witnessing more than 6.2% CAGR during the forecast period i.e., between 2024-2036.

North America industry is poised to account for largest revenue share by 2036, on account of the presence of a highly developed healthcare system, large volume of organ transplantation procedures performed in the region, high adoption of innovative transplant diagnostic technologies (includes HLA typing) among medical professionals and technological advancements in the field of transplant diagnostics.

The major players in the market are Immucor, Inc., Illumina, Inc., CareDx, Inc., QIAGEN N.V., Bio-Rad Laboratories, Inc., F. Hoffman-La Roche Ltd., Biofortuna Limited, Takara Bio Inc., Omixon Inc., and others.
HLA Typing for Transplant Market Report Scope
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample